Evidence map›Paper›PMID 42689133›Full record

ArticleLaryngoscope investigative otolaryngology2026

Large Language Models Versus Multidisciplinary Tumor Board Decisions in Thyroid Cancer.

Bayram Barış Büyük, Arzu Or Koca, Felat Toprak, Aslı Ayan, Tuncay Tunçcan, Ayça Arslan, ArzuBetül Duran, Elif Akyol Şen, Ömer Semih Budak, Alptekin Gürsoy and 1 more

Abstract read
In one paragraph

Article in Laryngoscope investigative otolaryngology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bayram Barış BüyükDepartment of Otorhinolaryngology University of Health Sciences Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital Ankara Turkey.ORCID https://orcid.org/0000-0003-2304-7963
Arzu Or KocaDepartment of Endocrinology and Metabolism Dr. Abdurrahman Yurtaslan Ankara Onkoloji Education and Research Hospital, University of Health Sciences Ankara Turkey.ORCID https://orcid.org/0000-0001-8433-4769
Felat ToprakDepartment of Otorhinolaryngology University of Health Sciences Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital Ankara Turkey.ORCID https://orcid.org/0000-0002-5952-7718
Aslı AyanDepartment of Nuclear Medicine Gulhane School of Medicine University of Health Sciences Ankara Turkey.ORCID https://orcid.org/0000-0001-6311-1785
Tuncay TunçcanDepartment of Otorhinolaryngology University of Health Sciences Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital Ankara Turkey.ORCID https://orcid.org/0000-0003-3321-5772
Ayça ArslanDepartment of Otorhinolaryngology University of Health Sciences Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital Ankara Turkey.ORCID https://orcid.org/0000-0002-9469-1468
ArzuBetül DuranDepartment of Otorhinolaryngology University of Health Sciences Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital Ankara Turkey.ORCID https://orcid.org/0000-0002-4121-7439
Elif Akyol ŞenDepartment of Otorhinolaryngology University of Health Sciences Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital Ankara Turkey.ORCID https://orcid.org/0000-0002-0414-3995
Ömer Semih BudakDepartment of Otorhinolaryngology University of Health Sciences Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital Ankara Turkey.ORCID https://orcid.org/0009-0006-4657-436X
Alptekin GürsoyDepartment of Endocrinology and Metabolism Dr. Abdurrahman Yurtaslan Ankara Onkoloji Education and Research Hospital, University of Health Sciences Ankara Turkey.ORCID https://orcid.org/0000-0002-0494-9200
Caner KılıçDepartment of Otorhinolaryngology University of Health Sciences Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital Ankara Turkey.ORCID https://orcid.org/0000-0003-2879-2524

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Large language models (LLMs) are increasingly proposed as clinical decision-support tools; however, their agreement with real-world multidisciplinary tumor board (MDT) decisions remains insufficiently investigated in thyroid oncology. To evaluate the concordance between treatment recommendations generated by ChatGPT 5.2 and Gemini 3.0 and decisions made by a tertiary multidisciplinary thyroid tumor board. Methods: This study included 59 consecutive patients discussed at a tertiary MDT between August and December 2025. Anonymized clinical data, including demographics, ultrasonographic findings, and Bethesda cytology, were provided to both LLMs using standardized structured prompts. MDT decisions were defined as the reference standard. Agreement was assessed using exact concordance rates and Cohen's kappa ( Results: ChatGPT 5.2 achieved a concordance rate of 71.2% (42/59), demonstrating substantial agreement ( Conclusions: While LLMs demonstrate promising concordance in standardized thyroid cancer management, they are best positioned as supportive decision aids-such as in MDT preparation and workflow streamlining-rather than replacements for expert multidisciplinary evaluation, particularly in complex clinical scenarios. Level of Evidence: 3.

Indexed as

artificial intelligencedecision support systemslarge language modelsmultidisciplinary carethyroid neoplasms

Identifiers

PMID42689133
PMCPMC13536480

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.